Financial Performance1Q results significantly above expectations with revenues of $77+ million, approximately 7% higher than the consensus estimate of $72 million.
Future OutlookFull-year revenue expectations are now at the high end of the company's previous guidance range, demonstrating confidence in the company's financial outlook.
Market PositionSurvey results show increasing traction in the US as refractive surgery gains more acceptance with more training, papers, and great outcomes.